Rheumatoid Arthritis Treatment After Methotrexate: The Durability of Triple Therapy Versus Etanercept

ConclusionIn RA patients with suboptimal methotrexate response randomized to receive triple therapy or methotrexate‐etanercept, the former was found to be significantly more durable. Given cost differences and similar outcomes, the variable durability demonstrated provides additional evidence supporting conventional combinations over biologic agent combinations as the first choice after methotrexate inadequate response.

Source: Arthritis Care and Research - September 6, 2017 Category: Rheumatology Authors: Shana M. Peper, Robert Lew, Ted Mikuls, Mary Brophy, Denis Rybin, Hongseng Wu, James O'dell Tags: Original Article Source Type: research